Assessing the impact of FDG-PET in the management of anal cancer

Radiotherapy and Oncology

Volumn 87, Issue 3, 2008, Pages 376-382

  Nguyen, Brandon T ^a   Joon, Daryl Lim ^a   Khoo, Vincent ^b   Quong, George ^a   Chao, Michael ^c   Wada, Morikatsu ^a   Joon, Michael Lim ^a   See, Andrew ^a   Feigen, Malcolm ^a   Rykers, Kym ^a   Kai, Cynleen ^a   Zupan, Eddy ^a   Scott, Andrew ^a  

^a AUSTIN HEALTH   (Australia)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Radiation Oncology Victoria   (Australia)

Author keywords

Anal carcinoma; FDG PET; Follow up; Radiotherapy; Response; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 46549083356     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.04.003     Document Type: Article

References (44)

1. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. IARC Scientific Publication No. 155, vol. VIII. Lyons: International Agency for Research on Cancer; 2002.
2. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., and Daling J.R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101 (2004) 281-288
3. Palefsky J.M. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. Aids 8 (1994) 283-295
4. Gutte H., Hojgaard L., and Kjaer A. Early clinical experience and impact of 18F-FDG PET. Nucl Med Commun 26 (2005) 989-994
5. Cotter S.E., Grigsby P.W., Siegel B.A., et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 720-725
6. Trautmann T.G., and Zuger J.H. Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 7 (2005) 309-313
7. Anderson C., Koshy M., Staley C., et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 69 (2007) 155-162
8. Schwarz J.K., Siegel B.A., Dehdashti F., Myerson R.J., Fleshman J.W., and Grigsby P.W. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys (2007)
9. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
10. Pintor M.P., Northover J.M., and Nicholls R.J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 76 (1989) 806-810
11. Touboul E., Schlienger M., Buffat L., et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73 (1994) 1569-1579
12. Klas J.V., Rothenberger D.A., Wong W.D., and Madoff R.D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 85 (1999) 1686-1693
13. Bai Y.K., Cao W.L., Gao J.D., Liang J., and Shao Y.F. Surgical salvage therapy of anal cancer. World J Gastroenterol 10 (2004) 424-426
14. Meeker Jr. W.R., Sickle-Santanello B.J., Philpott G., et al. Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 57 (1986) 525-529
15. Sischy B., Doggett R.L., Krall J.M., et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 81 (1989) 850-856
16. Scherrer A., Reboul F., Martin D., Dupuy J.C., and Menu Y. CT of malignant anal canal tumors. Radiographics 10 (1990) 433-453
17. Drieskens O., Oyen R., Van Poppel H., Vankan Y., Flamen P., and Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 32 (2005) 1412-1417
18. Gearhart S.L., Frassica D., Rosen R., Choti M., Schulick R., and Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13 (2006) 397-404
19. Grigsby P.W., Siegel B.A., and Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19 (2001) 3745-3749
20. Lamoreaux W.T., Grigsby P.W., Dehdashti F., et al. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 733-737
21. Boman B.M., Moertel C.G., O'Connell M.J., et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 54 (1984) 114-125
22. Gerard J.P., Chapet O., Samiei F., et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 92 (2001) 77-84
23. Golden G.T., and Horsley III J.S. Surgical management of epidermoid carcinoma of the anus. Am J Surg 131 (1976) 275-280
24. Stearns Jr. M.W., Urmacher C., Sternberg S.S., Woodruff J., and Attiyeh F. Cancer of the anal canal. Curr Probl Cancer 4 (1980) 1-44
25. Wade D.S., Herrera L., Castillo N.B., and Petrelli N.J. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 169 (1989) 238-242
26. Perera D., Pathma-Nathan N., Rabbitt P., Hewett P., and Rieger N. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum 46 (2003) 1027-1029
27. Bobin J.Y., Gerard J.P., Chapet O., Romestaing P., and Isaac S. Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation. Cancer Radiother 7 Suppl. 1 (2003) 85s-90s
28. Damin D.C., Rosito M.A., and Schwartsmann G. Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol 32 (2006) 247-252
29. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
30. Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 11 (1985) 1587-1593
31. Huang K., Haas-Kogan D., Weinberg V., and Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 13 (2007) 895-900
32. Rich T.A., Ajani J.A., Morrison W.H., Ota D., and Levin B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 27 (1993) 209-215
33. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., and Catton C.N. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
34. Ryan DP, Willet CG. Clinical features, staging and treatment of anal cancer. UptoDate, Version 14.2. 2006.
35. Fukunaga H., Sekimoto M., Ikeda M., et al. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol 12 (2005) 561-569
36. Sakurai H., Suzuki Y., Nonaka T., et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value. Gynecol Oncol 100 (2006) 601-607
37. Chapet O., Gerard J.P., Riche B., Alessio A., Mornex F., and Romestaing P. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
38. Tarantino D., and Bernstein M.A. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system. Dis Colon Rectum 45 (2002) 16-22
39. Goldman S., Norming U., Svensson C., and Glimelius B. Transanorectal ultrasonography in the staging of anal epidermoid carcinoma. Int J Colorectal Dis 6 (1991) 152-157
40. Giovannini M., Bardou V.J., Barclay R., et al. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy 33 (2001) 231-236
41. Roseau G., Palazzo L., Colardelle P., Chaussade S., Couturier D., and Paolaggi J.A. Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal. Gastrointest Endosc 40 (1994) 447-450
42. Roach S.C., Hulse P.A., Moulding F.J., Wilson R., and Carrington B.M. Magnetic resonance imaging of anal cancer. Clin Radiol 60 (2005) 1111-1119
43. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
44. Saksena M.A., Saokar A., and Harisinghani M.G. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 58 (2006) 367-374